chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a nurse practitioner concerning a pt who was vaccinated with a dose of varicella virus vaccine live (two lot #'s provided: Lot # 625903/0046H or Lot # 624441/1105E). Sometime between 01/17/04 and 02/05/04, the pt developed chickenpox with over 300 lesions.  The child may have experienced a fever above 103 degrees Fahrenheit, a cough, abdominal pain, and/or itching. The child received unknown symptomatic treatment. The child may have seen a physician. The reporter also indicated that 21 other students were vaccinated with a dose of varicella virus vaccine live and six students developed varicella with more than 50 lesions and fifteen students developed varicella with less than 50 lesions. Additional information has been requested.
student was sitting on the 3rd bleacher from the floor in the gym post inj;apparently fainted & tumbled to the floor;
This spontaneous report as received from a pharmacist refers to a patient of unknown age. Reporter reported that the patient received PNEUMOVAX 23 (lot #0595AA exp 08/30/2012) on 09/09/2012. No adverse symptoms reported. Additional information has been requested.
Patient report feeling dizzy and nauseous with periods of vertigo.  Patient given 4mg of P.O Ondansetron and rest.  Patient reports feeling better 60 minutes after medication was given.  Patient voided and was cleared to go home per in house medical doctor.  discharged to home with wife.
On 9/15/2021 I woke up with a swollen lymph node bilateral from my ears to neck. I ran fever of 100.0 for majority of the day on Monday. I missed 3 days of work. My doctor ordered titers for me to get on 10/1/2021.
I noticed a rash affecting my skin. The rash started on my neck and slowly started to cover my torso, arms and thighs. It was a severe rash. The skin was red and it broke out on some areas of my neck.
inj site tender to touch, 4cm x 6cm erythema w/urticaria surrounding site;rxn started sometime between noon & 4PM on 7APR98;area red all day 8APR98, DPH @ bedtime;9APR98 areas light;referred to MD for eval;
received vaccine on May 4 and on 6/23/2021 reports her arm started to hurt similar to how it did after she received the vaccine.  Left arm pain, arm feels heavy. No nausea, fatigue or dizziness.
Facial swelling on cheek developed the next day. Started on left cheek, then switched to right cheek. No swelling of lips, tongue, or throat. No difficulty breathing
10/2/2008 Rash appeared in clusters on R side of back in dermatome distribution and also in L groin in cluster and L flank. Patient was seen 10/6/2008 in my office. Rash was puritic and some areas were scabbed from scratching. There were no vessicles or oozing.
Chicken Pox developed 4 days post vaccination about 15-20 bumps.
feels hard (at injection site); left arm became sore; lumpy at injection site/ puffy at the injection site; Interchange of vaccine products; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products), PAIN IN EXTREMITY (left arm became sore), VACCINATION SITE MASS (lumpy at injection site/ puffy at the injection site) and VACCINATION SITE INDURATION (feels hard (at injection site)) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 067F21A) for COVID-19 vaccination.    Co-suspect product included non-company product COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 10-Mar-2021, the patient received dose of COVID-19 VACCINE NRVV AD26 (JNJ 78436735) (JANSSEN COVID-19 VACCINE) (Intramuscular) 1 dosage form. On 14-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). On 15-Nov-2021, the patient experienced PAIN IN EXTREMITY (left arm became sore) and VACCINATION SITE MASS (lumpy at injection site/ puffy at the injection site). On 17-Nov-2021, the patient experienced VACCINATION SITE INDURATION (feels hard (at injection site)). On 14-Nov-2021, INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) had resolved. At the time of the report, PAIN IN EXTREMITY (left arm became sore), VACCINATION SITE MASS (lumpy at injection site/ puffy at the injection site) and VACCINATION SITE INDURATION (feels hard (at injection site)) outcome was unknown.            Patient stated that she takes other medications and Concomitant medication details were not provided. Treatment information was not provided. Patient had no known drug or food allergies.
Baby found by mother in am, nonresponsive. Nurse follow up on 05/18/04 states: SIDS.
I got the 1st dose of the Pfizer Covid vaccine on day 3 of my period.  Normally I have very regular periods that end completely by day 7. But since getting the vaccine, my period has lasted for 14 days with no signs of stopping.  On day 13, for a few hours I bled so heavily that I went to urgent care.  Since it was Saturday night and they're a small clinic, they couldn't conduct any real lab tests and I must wait till Monday to see my obgyn.  Prior to getting the vaccine, I NEVER had this much excess bleeding, and I never bled longer than 7 days (now it's been 14 days and counting) I am alarmed that the vaccine has clearly affected the length and intensity of my menstrual cycle, and no doctor seems to know why.
Breast cancer; Shingrix could be administered in an IM site other than the deltoid; Shingrix could be administered in an IM site other than the deltoid; This case was reported by a other health professional via call center representative and described the occurrence of breast cancer in a 73-year-old female patient who received Herpes zoster (Shingrix) (batch number 9227H, expiry date 28th February 2020) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In October 2019, the patient received the 1st dose of Shingrix. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, between 5 and 6 months after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced breast cancer (serious criteria GSK medically significant), circumstance or information capable of leading to medication error and vaccine administered at inappropriate site. On an unknown date, the outcome of the breast cancer, circumstance or information capable of leading to medication error and vaccine administered at inappropriate site were unknown.   It was unknown if the reporter considered the breast cancer to be related to Shingrix.  Additional details were provided as follows: The patient could not say if this was before or after dose one of Shingrix, the patient was diagnosed with breast cancer and had surgery with lymph node removal.  The reporter inquired if Shingrix could be administered in an intramuscular site other than the deltoid which led to circumstance or information capable of leading to medication error and vaccine administered at inappropriate site The follow up consent was granted.
Vaccines were kept frozen until they are ready for administration means they would be in fridge about 1-3 days; administered moderna vaccines beyond the use date and/or expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered moderna vaccines beyond the use date and/or expired) and PRODUCT STORAGE ERROR (Vaccines were kept frozen until they are ready for administration means they would be in fridge about 1-3 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Dec-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered moderna vaccines beyond the use date and/or expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines were kept frozen until they are ready for administration means they would be in fridge about 1-3 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered moderna vaccines beyond the use date and/or expired) and PRODUCT STORAGE ERROR (Vaccines were kept frozen until they are ready for administration means they would be in fridge about 1-3 days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided.  It was report that the vaccines were tend to store with 1 to 3 bottles in the fridge to thaw out and to be ready for the patients when needed and at worst scenarios vaccines would have been in the fridge for about a week if no one came in to be vaccinated.  No treatment medication information was provided.
UNUSUAL SIDE EFFECT; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN Expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced unusual side effect. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of unusual side effect was not reported. This report was non-serious.
Hello I received my Covid Vaccination on 12/23/20 7:56 am at Healthcare Clinic.  I waited 15 minutes after the vaccination and then went and stayed home.  Six hours later my arm started to become very painful (no surprise) I then felt an overwhelming fatigue and sadness.  I had tears just streaming down my face for about 3 minutes.  I laid down and awoke later that night still feeling very fatigued.  I showered and crawled back to bed I awoke the next day at mid-morning, still tired but 60 % better.  I stayed awake for a few hours, showered, changed the bed sheets and went back to bed for several hours more.  I awoke tired ate a lite dinner and went back to bed.  I awoke at 8:00 on Christmas day feeling fine, just like my old self.  If you need any more information just call.  Oh my vaccine information is: PFIZER EJ1685 12/23/20 1st dose.  Thank you,   Medical Interpreter Center for Advanced Pediatrics Endocrine Department.
Localized hives lasting 2 weeks which spread to abdomen. Symptoms of lethargy, nausea, loss of appetite, onset to redness/swelling within hours of injection. Hives about 2 days later.
He was injected with the three shots two and one arm one and the other in the upper part of his arm ,  I am not sure which ones were new to him besides I?m positive the HPV was a new shot to him he hadn?t had that one before. The following day early in the morning  he started complaining of a headache and his arms being really sore to the point he couldn?t move them as the day went on he was with my father so my dad had given him Tylenol and he had complained of a headache and been sleeping a lot by the time I got home from work he was complaining of a headache and he put ice pack on his head and took a shower and took more ibuprofen and they came out and I took his temperature and it was 104.6   His symptoms ranged Immense headache high fever of 103.6 to 104.6 vomiting rash on his chest brought him to the ER  twice the following day after his shots because it started with an extreme headache and a temperature of 104.6 and a rash they told me it might?ve been strep and sent me home and told me to give him  Tylenol 975 mg every 46 hours and check his temperature. Two hours after getting home his temperature spiked back up to 103.7 he was complaining that his head hurt and then puked from one end of my house to the other called the ER back they had me go back down they gave him an anti-vomiting medication and Motrin and told me to alternate the Motrin and the Tylenol and to give them the zofran if needed in the morning And now they thought it might be a virus but they weren?t sure. I can?t say for sure it was from the shop but I needed to share this information just in case I am to follow up with his primary care physician on Monday when the clinic opens back up
Hives around my injection site; Cold sweat; My tongue went numb and temporarily enlarged; My tongue went numb and temporarily enlarged; Throat swelled; Difficulty swallowing; Grew overwhelmingly hot; Weak; Tingly on the left side of my body; Dizzy; This is a spontaneous report from a non-contactable consumer (patient). A 27-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) dose 1 via an unspecified route of administration, administered in the left arm on 06Apr2021 at 16:30 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included arthritis from an unknown date and unknown if ongoing (Mild arthritis), haematuria from an unknown date and unknown if ongoing (Mild (rare) acute hematuria), factor V leiden mutation from an unknown date and unknown if ongoing (Heterozygous for FACTOR V clotting disorder), anaemia from an unknown date and unknown if ongoing (occasional history of anemia). Concomitant medications included levonorgestrel (KYLEENA) taken for an unspecified indication, start and stop date were not reported; vitamin D for an unspecified indication, start and stop date were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient reported, "5 minutes after receiving the vaccine, I grew overwhelmingly hot, but this subsided. An hour later, I broke into a cold sweat, my tongue went numb and temporarily enlarged, my throat swelled and I had difficulty swallowing. Near the 2 hour mark, I grew considerably weak, tingly on the left side of my body, and dizzy. The swelling and numbness subsided within 5 hours and emergency doses of steroids and Benadryl. The next morning, I had hives around my injection site." Treatment for the events included prednisone, diphenhydramine (BENADRYL), and saline solution. The patient recovered from the events, grew overwhelmingly hot, tongue went numb and temporarily enlarged, and throat swelled. The patient was recovering from the events, cold sweat, difficulty swallowing, weak, tingly on the left side of my body, and dizzy. The outcome of the event, hives around my injection site was unknown.
throat tightness, cough, h/a, chills, myalgias, fever;
Physician wrote intentional prescription for a patient less than 50 years old to receive Shingrix; This case was reported by a pharmacist via call center representative and described the occurrence of off label use in a 32-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included herpes zoster.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced off label use. On an unknown date, the outcome of the off label use was unknown.  Additional details provided were as follows: Pharmacist reported that physician wrote intentional prescription for a patient less than 50 years old to receive Shingrix vaccine due to patient's medical history of herpes zoster virus which led to off label use. Vaccine had not yet been administered. Pharmacist did not provided date of birth but stated that the patient's current age was 32 years. Reporter consented to follow up. Pharmacist provided permission for follow-up.
A report was received from a health professional on 9/14/01 concerning a 35 year old female patient who was hospitalized due to anaphylaxis after receiving a Fluvirin vaccine on 9/11/01. The patient is allergic to Sulfa drugs and metoclopramide. The patient received a dose of flu vaccine 1 year previously with no problems. On 9/11/02, the patient experienced anaphylaxis including redness/itching, difficulty breathing and chest pain 10 minutes after receiving a Fluvirin vaccination. Therapeutic measures taken as a result of this event included Diphenhydramine 50mg IV and Epinephrine 1:1000, which were administered IV. The patient then became blue, developed red welts on chest and extreme pallor of extremities, with apnea for about 30 seconds. Oxygen was administered and the patient was admitted to hospital on 9/11/01 with symptoms abating but continuing. The patient recovered on 9/13/01 and was due to be discharged from hospital on 9/14/01. The reporter has assessed the relationship of study medication to the event as possible.
pt recv vax & exp hypotension & urticaria;ER or MD visit was required;pt sx were treated w/DPH, lasted 2 days & resolved;vaccination series was discontinued;
hurting more in different joints now; This is a spontaneous report from a contactable consumer (patient). A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: FD8448, Expiration Date: not reported) via an unspecified route of administration in right arm on 19Aug2021 as dose 1, single for COVID-19 immunization (at the age of 64-year-old). Medical history included hurting and cataract. The patient's concomitant medications were not reported. The patient experienced hurting more in different joints now on an unspecified date in 2021. It was reported that, she took the first covid shot last Thursday, she wanted to find out if she could take tramadol. She saw something about anti inflammatory cannot be taken and she was just hurting. Patient clarified that, she had not consumed the tramadol or anti inflammatory yet, she didn't take anything because she was fine, she had only taken a Tylenol. Her hurting was something that was prior to receiving the covid vaccine, it was before. She was just hurting more in different joints now, she just did not think about it. She was more worried about what she saw on the internet that 4 weeks down the line, people getting moderna broke out in shingles. she was waiting to find out more information first. The outcome of the events was unknown.  Additional information is requested.  Follow-up attempts completed. No further information expected
Patient admitted with elevated LFTs. Patient underwent ERCP. Discharged home after 4 days. Hospital admission was within 6 weeks of receiving the COVD vaccine.
Information has been received from a physician and a registered nurse concerning a 83-year-old female who during the week of 22-OCT-2007 was vaccinated subcutaneously with a dose of zoster vaccine live (Oka/Merck) (lot# 658604/1088U). During the week of 22-OCT-2007, the patient experienced a 2 inch round, red swelling at the injection site. It was unspecified if medical attention was sought. No outcome was reported for the patient. No product quality complaint was involved. Additional information has been requested.
shoulder is swallen after 7 days of receiving the shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of SWELLING (shoulder is swallen after 7 days of receiving the shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (shoulder is swallen after 7 days of receiving the shot). At the time of the report, SWELLING (shoulder is swallen after 7 days of receiving the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    Reporter did not allow further contact This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-May-2021 and was forwarded to Moderna on 22-May-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of SWELLING (shoulder is swallen after 7 days of receiving the shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SWELLING (shoulder is swallen after 7 days of receiving the shot). At the time of the report, SWELLING (shoulder is swallen after 7 days of receiving the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.    Reporter did not allow further contact
seizure; high fever; Initial information was received on 29-Dec-2020 regarding an unsolicited valid serious case from a consumer(patient) via other company.  This case involves a 24-year-old female patient who experienced seizure and high fever (pyrexia), while she received TETANUS TOXOID, DIPHTHERIA TOXOID, TYPHOID VACCINE and CHOLERA VACCINE.  Medical history, medical treatment, concomitant medications, vaccination and family history were not provided. At the time of the event, the patient had ongoing latex allergy (Rubber sensitivity) and injectable Iodine allergy.  On an unknown date, the patient received a dose of each suspect TYPHOID VACCINE produced by unknown manufacturer and suspects DIPHTHERIA TOXOID, TETANUS TOXOID and CHOLERA VACCINE not produced by Sanofi Pasteur (lot number and expiry date not reported) all vaccines via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious seizure and high fever (pyrexia) 6 hours following the administration of TYPHOID VACCINE, DIPHTHERIA TOXOID, TETANUS TOXOID and CHOLERA VACCINE. The patient was hospitalized for this event. (hospitalization duration 4 days). The event seizure was assessed as medically significant.  It was reported that, the patient having previous reactions to vaccines when she was 24 years old prior to trip and doctors told during hospitalization that she should not have received all four vaccines at the same time. Reporter asked if she can receive the COVID-19 vaccine, she also told that (this whole thing has been a waste of her time).  Other relevant laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for both the events.  Information on the lot number was requested.; Sender's Comments: This case concerns a 24-year-old female patient who experienced seizure and pyrexia after vaccination with TETANUS TOXOID, DIPHTHERIA TOXOID, TYPHOID VACCINE and CHOLERA VACCINE. The time to onset is compatible. The patient has allergies to latex and injectable iodine. Further information regarding medical condition at the time of vaccination, previous vaccinations and laboratory investigations excluding alternative etiologies is needed for complete assessment of the case. Based upon the reported information, the role of an individual vaccine cannot be assessed.